Recent patient studies surrounding this compound, specifically the 120mg formulation ZPHC ZPHC, reveal a considerable effect on body mass reduction and associated health conditions . Researchers posit that this combined compound, targeting both GLP-1 and GIP systems, has the potential to provide a noteworthy breakthrough in the management of overwe